404
Clinical Mass Spectrometry Market Report
Global Clinical Mass Spectrometry Market, Dynamics, Trends, and Market Analysis
The report on Global Clinical Mass Spectrometry Market is segmented by Product (Gas chromatography-mass spectrometry, Liquid chromatography–mass spectrometry, Maldi TOF mass spectrometer, Capillary electrophoresis–mass spectrometry, Ion mobility spectrometry-mass spectrometry), By Application (Drug Discovery, Clinical Testing, Proteomics), By End-Use (Hospitals, Diagnostic Centers, Research Laboratories) and Region. This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global clinical mass spectrometry market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The clinical mass spectrometry market size is expected to reach USD 1,242.3 million in the coming years.
Bruker (The U.S), Thermo Fisher Scientific Inc. (The U.S), Danaher (The U.S), Agilent Technologies (The U.S), PerkinElmer Inc. (The U.S), Shimadzu Corporation (Japan), Kore Technologies (India), BME Bergmann (Netherlands), Mass Spectrometry Instruments (The U.S) and Photonics GmbH (The U.S) are among the key players in the clinical mass spectrometry market.
The clinical mass spectrometry market is expected to witness an impressive growth of 7.9% CAGR in the foreseeable future.
North America witnessed the highest market share in 2020 and is projected to grow at a robust CAGR.
The clinical testing segment garnered the highest market share in 2020 and is likely to register a healthy CAGR.
Rapid increase in technological developments in spectrometry, advancement of healthcare technologies, and growing R&D investments are the factors driving the growth of clinical mass spectrometry market.
Clinical mass spectrometry companies, Hospitals, Diagnostic centers and laboratories, Academic Institutions, Research centers & organizations are the target audience in the clinical mass spectrometry market.